As the electoral fog clears and promising developments on the CV19 vaccine front have materialized, what is to stop us
jumping straight into a reflation portfolio, fully geared? Should we be concerned about the gap between a still gloomy present and the blue sky of the post-Covid uplands? Can all the imbalances just be magicked away by policy levers or does something nastier have to happen in the meantime? Julian’s presentation here and the feedback of institutional clients battle this one out. The Asian Tiger, however, may be getting ready to party through the decade.